ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.394,93
-0,11%
S&P 500
6.101,24
-0,29%
Dow Jones
44.424,25
-0,32%
Euro vs US Dollar
1,05025
0,00%
Bitcoin
104.527,93
-0,19%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Argent Biopharma Limited (RGT)

  7. Argent Biopharma Limited (RGT) News

RGT

Argent Biopharma (RGT)

Argent Biopharma Limited
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:RGT
DatumZeitQuelleÜberschriftSymbolFirma
31/12/202409h00RNS Regulatory NewsLondon Stock Exchange Notice Cancellation - Argent Biopharma LimitedLSE:RGTArgent Biopharma Limited
16/12/202409h13RNS Non-RegulatoryArgent Biopharma Limited Additional Information for ShareholdersLSE:RGTArgent Biopharma Limited
29/11/202412h52Alliance NewsAlliance NewsArgent BioPharma to delist from LSE; hints at future dual US listingLSE:RGTArgent Biopharma Limited
29/11/202408h00RNS Regulatory NewsArgent Biopharma Limited ASX & LSE Listing UpdateLSE:RGTArgent Biopharma Limited
28/11/202410h09RNS Regulatory NewsArgent Biopharma Limited Result of AGMLSE:RGTArgent Biopharma Limited
31/10/202408h00RNS Regulatory NewsArgent Biopharma Limited September 2024 Quarterly ReportLSE:RGTArgent Biopharma Limited
25/10/202408h13RNS Regulatory NewsArgent Biopharma Limited Dispatch of Annual General Meeting DocumentsLSE:RGTArgent Biopharma Limited
24/10/202408h24RNS Regulatory NewsArgent Biopharma Limited Placing to Raise A$200,000LSE:RGTArgent Biopharma Limited
15/10/202409h56RNS Regulatory NewsArgent Biopharma Limited Holding(s) in CompanyLSE:RGTArgent Biopharma Limited
15/10/202409h54RNS Regulatory NewsArgent Biopharma Limited Director/PDMR ShareholdingLSE:RGTArgent Biopharma Limited
10/10/202410h10Alliance NewsAlliance NewsIN BRIEF: Argent BioPharma refinances AUD300,000 in convertible notesLSE:RGTArgent Biopharma Limited
09/10/202408h00RNS Regulatory NewsArgent Biopharma Limited Refinancing of Convertible Security AgreementLSE:RGTArgent Biopharma Limited
01/10/202411h33RNS Regulatory NewsArgent Biopharma Limited Result of MeetingLSE:RGTArgent Biopharma Limited
30/09/202410h34RNS Regulatory NewsArgent Biopharma Limited Annual Report for the year ended 30 June 2024LSE:RGTArgent Biopharma Limited
25/09/202408h50RNS Regulatory NewsArgent Biopharma Limited Date of AGM & Closing Date of Director NominationsLSE:RGTArgent Biopharma Limited
23/09/202408h24RNS Regulatory NewsArgent Biopharma Limited ASX Delisting UpdateLSE:RGTArgent Biopharma Limited
12/09/202408h00RNS Regulatory NewsArgent Biopharma Limited Director/PDMR ShareholdingLSE:RGTArgent Biopharma Limited
10/09/202408h00RNS Non-RegulatoryArgent Biopharma Limited CannEpil - Technical OverviewLSE:RGTArgent Biopharma Limited
09/09/202408h00RNS Non-RegulatoryArgent Biopharma Limited CimetrA - Technical OverviewLSE:RGTArgent Biopharma Limited
06/09/202408h00RNS Regulatory NewsArgent Biopharma Limited Company PresentationLSE:RGTArgent Biopharma Limited
30/08/202419h37Alliance NewsAlliance NewsIN BRIEF: Argent Biopharma loss narrows amid investment gainLSE:RGTArgent Biopharma Limited
30/08/202408h10RNS Regulatory NewsArgent Biopharma Limited 30 June 2024 Preliminary Financial ReportLSE:RGTArgent Biopharma Limited
27/08/202408h05RNS Regulatory NewsArgent Biopharma Limited Letter from the CEOLSE:RGTArgent Biopharma Limited
27/08/202408h00RNS Regulatory NewsArgent Biopharma Limited Notice of General MeetingLSE:RGTArgent Biopharma Limited
21/08/202422h55Alliance NewsAlliance NewsTRADING UPDATES: Hellenic Dynamics loan delay; Argent's Sintef tie-upLSE:RGTArgent Biopharma Limited
21/08/202408h00RNS Regulatory NewsArgent Biopharma Limited SINTEF Collaboration for Chronic Wound ManagementLSE:RGTArgent Biopharma Limited
15/08/202408h20RNS Regulatory NewsArgent Biopharma Limited Voluntary Delisting From ASXLSE:RGTArgent Biopharma Limited
30/07/202409h00RNS Regulatory NewsArgent Biopharma Limited June 2024 Quarter Activity Report and Cash FlowLSE:RGTArgent Biopharma Limited
16/07/202421h23Alliance NewsAlliance NewsTRADING UPDATES: Cirata to raise cash; Cap-XX teams with SchurterLSE:RGTArgent Biopharma Limited
16/07/202410h58RNS Regulatory NewsArgent Biopharma Limited Placing to Raise US$2,000,000LSE:RGTArgent Biopharma Limited
 Showing the most relevant articles for your search:LSE:RGT

Kürzlich von Ihnen besucht

USOTC
BASFY
BASF (QX)
TG
D7G
Nel ASA
NYSE
DIS
Walt Disney
TG
BAYN
Bayer
NASDAQ
TSLA
Tesla
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
COIN
ETHUSD
Ethereum
TG
MBG
MercedesBenz
COIN
AVAXUSD
Avalanche
TG
ALV
Allianz
TG
CBK
Commerzbank
NYSE
MCD
McDonalds
COIN
BTCUSD
Bitcoin
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten